New treatment for blood cancer
September is blood cancer awareness month, and it is the third leading cause of cancer deaths in the U.S. That includes leukemia, lymphoma, myeloma, and Hodgkin’s disease. But a new treatment is helping them live longer. While more than a third of blood cancer patients still do not survive five years after diagnosis, the groundbreaking CAR-T therapy is helping a lot. It falls under the immunotherapy umbrella and utilizes the body’s own white blood cells.
